- Successful Treatment of Lupoid Cutaneous Leishmaniasis with Glucantime and Topical Trichloroacetic Acid (A Case Report)
-
Nilforoushzadeh MA, Sadeghian , Jaffary F, Ziaei H, Shirani-Bidabad L, Mahzoni P
- KMID: 1720562
- Korean J Parasitol.
- 2008 Sep;46(3):175-177.
- doi: 10.3347/kjp.2008.46.3.175
Lupoid leishmaniasis is a unique form of cutaneous leishmaniasis characterized by unusual clinical features and a chronic relapsing course, mostly caused by infection with Leishmania tropica. In this clinical form,... -
- CITED
-
- Close
- SHARE
-
- Close
- Cutaneous Leishmaniasis of the Lid: A Report of Nine Cases
-
Yaghoobi R, Maraghi S, Bagherani , Rafiei A
- KMID: 1098792
- Korean J Ophthalmol.
- 2010 Feb;24(1):40-43.
- doi: 10.3341/kjo.2010.24.1.40
Leishmaniasis is a parasitic disease caused by Leishmania species and is classified into three forms; cutaneous, mucocutaneous, and visceral. The eyelid is a rare site involved by leishmaniasis and only... -
- CITED
-
- Close
- SHARE
-
- Close
- Aureobasidium-Derived Soluble Branched (1,3-1,6) beta-Glucan (Sophy beta-glucan) Enhances Natural Killer Activity in Leishmania amazonensis-Infected Mice
-
Yatawara L, Wickramasinghe S, Nagataki M, Takamoto M, Nomura H, Ikeue Y, Watanabe Y, Agatsuma T
- KMID: 1720635
- Korean J Parasitol.
- 2009 Dec;47(4):345-351.
- doi: 10.3347/kjp.2009.47.4.345
The beta-glucans derived from yeast cell walls have been reported for having many immunomodulatory activities in vivo and in vitro. In this study, Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan)... -
- CITED
-
- Close
- SHARE
-
- Close
